TREX2 degrades cytosolic DNA, repressing cGAS-STING activation, leading to less apoptosis of tumor cells and downregulated CD8+ T cell infiltration in the TME, ultimately enhancing resistance to immunoblockade therapy [17]. This evidence concerns the gene CD8A and neoplasm.